HD-OPM Archive
Topics › Statins

N-of-1 trial: about 90% of statin side effects were nocebo

Louis Nervegna · May 21, 2025 · ♥ 13 reactions · 12 comments · original Facebook post
StatinsMyths, misinformation & controversies
↻ This is a repost. The main version (highest ranked) is N-of-1 trial: most statin side effects arose with placebo too, pointing to nocebo · Feb 24, 2025.
AI summary & key facts

Louis highlights a NEJM N-of-1 trial where statin-intolerant patients received statin, placebo and empty bottles in random months. Symptom burden on placebo was not different from statin, and half restarted statins.

On any given month, the participants were randomized to either a statin, a placebo, or nothing at all.

What happened is that participants reported very little side effects from taking nothing, but lots of side effects from taking either the placebo or the statin.

The only reasonable explanation for that is nocebo effect. In this study, 90% of the side effects were due to nocebo effect.

↪ Nocebo effect explained about 90% of symptoms in patients who quit statins (SAMSON trial)

People who are prone to conspiratorial lines of thinking about medical topics are much more likely to experience nocebo effect. This is why you should always take testimonials from these people with a grain of salt.

facebook.com/share/r/1BPLbqjcwe

#noceboHD #statinsHD #nejmHD #samsonHD

Research cited

Patients who had discontinued statins because of side effects received four one-month bottles of a statin, four bottles of placebo, and four empty bottles, randomly sequenced, each to be used for 1 month. Symptom burden with placebo was not significantly different to the symptom burden with the statin, and half the study participants were able to successfully restart statins.

← newer: Statin muscle side effects traced to HMG-CoA reductase gene older: Low HDL reflects insulin resistance; lose visceral fat and s →